DEX Ophthalmic Tissue Forceps, 23ga DEX NanoTapered AWH Forceps Recall
DEX Ophthalmic Tissue Forceps, 23ga DEX NanoTapered AWH Forceps, Model/Catalog Number: DVF4005-23
FDA recall Class II
Ongoing
FDA lists this Class II recall for DEX Ophthalmic Tissue Forceps, 23ga DEX NanoTapered AWH Forceps. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2069-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Mar 25, 2026
- FDA report date
- May 13, 2026
- Quantity in commerce
- 5 units
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
DEX Ophthalmic Tissue Forceps, 23ga DEX NanoTapered AWH Forceps, Model/Catalog Number: DVF4005-23
Affected model & UDI checker
Search the exact identifiers published for Z-2069-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| DVF4005-23 | DEX Ophthalmic Tissue Forceps, 23ga DEX NanoTapered AWH Forceps | Check source notice | Not specified |
| Not specified | DEX Ophthalmic Tissue Forceps, 23ga DEX NanoTapered AWH Forceps | Check source notice | 10817489021658 |
FDA code information
Lot Code: Model No: DVF4005-23 UDI-DI: (01)10817489021658(11)250924(17)280924(10)M50529 Lot Number: M50529 Expiration Date: 09/04/2028
Why was this product recalled?
Field Safety Corrective Action for IFU in DEX Forceps and Scissors.
What actions did KATALYST SURGICAL, LLC take?
A Field Safety Notification: Field Safety Corrective Action for IFU in DEX Forceps and Scissors dated 3/19/26 was sent to customers. FIELD SAFETY ACTIONS REQUIRED As a customer identified in the receipt of one or more of the affected lots, you are requested/required to take the following steps: 1. Please confirm receipt of this Field Safety Notification by email, either by replying to the sender or using the email addresses listed in the signature at the bottom of this notice. 2. Review the Individualized List of Affected Lot Numbers by Customer provided in the email for lots that were distributed to your facility. Identify all of these lots that currently remain in your stock and place them on hold. 3. Provide information to Katalyst Surgical team identifying which lots are currently in stock and on hold at your facility. Katalyst Surgical will send a replacement correct IFU for each affected box. 4. Upon receipt of the correct IFU, remove the incorrect IFU, replace the correct IFU in the box, and destroy the incorrect IFU. Approval for Modification including instructions will accompany the replacement IFUs. 5. We recommend you reach out to your customers/users of these DEX products with this information. Katalyst Surgical will gladly provide correct replacement IFU documents to you for further distribution. Katalyst Surgical deeply regrets the inconvenience this causes. We assure you of our continuous support and commitment to safety and quality. Please do not hesitate to contact our team if you have any further questions.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2069-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology